uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Medidata Solutions, Inc. Successfully Hosts Annual Conference Series July 12, 2017 Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn December 11, 2017 Repligen To Report Second Quarter 2017 Financial Results July 26, 2017
